# K120274: Deltamaxx 18 Microcoil System

- Pathway: 510(k) (Special)
- Applicant: Codman and Shurtleff, Inc.
- Decided: Mar 2, 2012 after 32 days
- Product code: HCG (Device, Neurovascular Embolization)
- Device class: 2
- Regulation: 21 CFR 882.5950
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K951256 (1995). 34 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 36 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K080379: Micrus Microcoil System, Deltapaq 10 Stretch Resistant, Micrus Endovascular Corporation (2008) Summary page 1.
- K080437: Micrus Microcoil System, Deltapaq 10 Cerecyte, Model CDF, Micrus Endovascular Corporation (2008) Summary page 1.
- K062036: Micrus Microcoil System Presidio-18, Model PC4, Micrus Endovascular Corporation (2006) Summary page 1.

## Most influential descendants
- K142429: CODMAN Microcoil Delivery System, DELTAMAXX Microcoil Delivery System, ORBIT GALAXY G2 Microcoil Delivery System, EnPower Control Cable, Connector Cable (2014), 0 descendants of its own

## Indications for use
The DELTAMAXX' M Microcoil Delivery System is intended for endovascular embolization of intracranial aneurysms, other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae, and is also intended for arterial and venous embolizations in the peripheral vasculature.

Source page: https://510kreport.com/device/K120274
Methodology: https://510kreport.com/methodology